An investigation of NOS2A promoter polymorphisms in Australian multiple sclerosis patients (Q56112201)

1

0 references

David R Booth

2

0 references

Bruce H Bennetts

3

0 references

Robert N S Heard

4

0 references

Graeme J Stewart

European Journal of Human Genetics

6

0 references

publication date

27 April 2005

0 references

published in

0 references

volume

13

0 references

issue

7

0 references

page(s)

815-822

0 references

cites work

Insights into the aetiology and pathogenesis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

A population-based study of multiple sclerosis in twins: update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

B-lymphocyte alloantigens associated with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

HLA-DR, -DQA1 and -DQB1 associations in Australian multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

Nitric oxide and the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

Inducible nitric oxide synthase in chronic active multiple sclerosis plaques: distribution, cellular expression and association with myelin damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

Our shifting understanding of the role of nitric oxide in autoimmune encephalomyelitis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

Genome-wide TDT analysis in a localized population with a high prevalence of multiple sclerosis indicates the importance of a region on chromosome 14q.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

Updated results of the United Kingdom linkage-based genome screen in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

Genomewide scan of multiple sclerosis in Finnish multiplex families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

A whole genome screen for linkage disequilibrium in multiple sclerosis confirms disease associations with regions previously linked to susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

An extended genome scan in 442 Canadian multiple sclerosis-affected sibships: a report from the Canadian Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

Linkage and association with the NOS2A locus on chromosome 17q11 in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor kappaB-binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

Binding of the transcription factor interferon regulatory factor-1 to the inducible nitric-oxide synthase promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

Association of a functional inducible nitric oxide synthase promoter variant with complications in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

Inducible nitric oxide synthase gene (NOS2A) haplotypes and the outcome of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

Inducible nitric oxide synthase polymorphism and fatal cerebral malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

The CCTTT polymorphism in the NOS2A gene is associated with dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

Haplotypic relationship between SNP and microsatellite markers at the NOS2A locus in two populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

Universal, robust, highly quantitative SNP allele frequency measurement in DNA pools.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

Single nucleotide polymorphism--disease relationships: statistical issues for the performance of association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

Functional analysis of human promoter polymorphisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

TRANSFAC: an integrated system for gene expression regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

Nitric oxide is a potential down-regulating molecule in autoimmune disease: inhibition of nitric oxide production renders PVG rats highly susceptible to EAE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

Inhibition of nitric oxide synthase initiates relapsing remitting experimental autoimmune encephalomyelitis in rats, yet nitric oxide appears to be essential for clinical expression of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

Haplotype tagging for the identification of common disease genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

Genetic Analysis of Multiple Sclerosis in Europeans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

7 January 2021

Multiple sclerosis, multiple genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

7 January 2021

Nitric oxide as a secretory product of mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

7 January 2021

Nitric oxide metabolite determinations reveal continuous inflammation in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

7 January 2021

Nucleotide and haplotypic diversity of the NOS2A promoter region and its relationship to cerebral malaria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

7 January 2021

No linkage or association of the nitric oxide synthase genes to multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

7 January 2021

No association of inducible nitric oxide synthase gene ( NOS2A ) to multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

7 January 2021

Detection of single-nucleotide polymorphisms with the WAVE DNA fragment analysis system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

7 January 2021

A genome-wide screen for linkage disequilibrium in Australian HLA-DRB1*1501 positive multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

7 January 2021

Mice with an inactivation of the inducible nitric oxide synthase gene are susceptible to experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

7 January 2021

A novel nitric oxide scavenger in combination with cyclosporine A ameliorates experimental autoimmune encephalomyelitis progression in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

7 January 2021

Inducible nitric oxide synthase gene expression and enzyme activity correlate with disease activity in murine experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

7 January 2021

Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

7 January 2021

Aminoguanidine, a selective inhibitor of the inducible nitric oxide synthase, has different effects on experimental allergic encephalomyelitis in the induction and progression phase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201422

7 January 2021